Literature DB >> 18333172

The role of chemoradiation therapy in locally advanced pancreatic cancer.

Rebekah R White1, Srinivas Reddy, Douglas S Tyler.   

Abstract

The majority of patients with pancreatic cancer present with disease that is unresectable due to local invasion. This article reviews the evidence (or lack thereof) that chemoradiation therapy (CRT) helps these patients in four areas: survival, tumor downstaging, palliation of obstructive symptoms, and pain control. We believe that CRT allows a small percentage of patients with locally advanced disease to undergo potentially curative resection while providing effective palliative treatment.

Entities:  

Year:  2005        PMID: 18333172      PMCID: PMC2023933          DOI: 10.1080/13651820510016506

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  38 in total

1.  Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer?

Authors:  B Launois; C Stasik; E Bardaxoglou; B Meunier; J P Campion; L Greco; F Sutherland
Journal:  World J Surg       Date:  1999-09       Impact factor: 3.352

2.  Surgical treatment of pancreatic tumors invading the spleno-mesenteric-portal vessels. An Italian Multicenter Survey.

Authors:  A M Taschieri; M Elli; M Rovati; G M Sampietro; M Cristaldi; P Danelli; M Pisacreta
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

3.  Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study.

Authors:  E Bajetta; M Di Bartolomeo; S C Stani; S Artale; S B Ricci; F Bozzetti; V Mazzaferro; L Toffolatti; R Buzzoni
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

4.  Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer.

Authors:  B J Fisher; F E Perera; W Kocha; A Tomiak; M Taylor; M Vincent; G S Bauman
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

5.  Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas.

Authors:  R R White; H I Hurwitz; M A Morse; C Lee; M S Anscher; E K Paulson; M R Gottfried; J Baillie; M S Branch; P S Jowell; K M McGrath; B M Clary; T N Pappas; D S Tyler
Journal:  Ann Surg Oncol       Date:  2001-12       Impact factor: 5.344

6.  Vascular involvement in pancreatic adenocarcinoma: reassessment by thin-section CT.

Authors:  E M Loyer; C L David; R A Dubrow; D B Evans; C Charnsangavej
Journal:  Abdom Imaging       Date:  1996 May-Jun

7.  Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.

Authors:  R C van Geenen; F J ten Kate; L T de Wit; T M van Gulik; H Obertop; D J Gouma
Journal:  Surgery       Date:  2001-02       Impact factor: 3.982

8.  Neoadjuvant radio-chemotherapy in advanced primarilynon-resectable carcinomas of the pancreas.

Authors:  S Kastl; T Brunner; O Herrmann; M Riepl; R Fietkau; G Grabenbauer; R Sauer; W Hohenberger; P Klein
Journal:  Eur J Surg Oncol       Date:  2000-09       Impact factor: 4.424

9.  Treatment perspectives in locally advanced unresectable pancreatic cancer.

Authors:  J Jeekel; A D Treurniet-Donker
Journal:  Br J Surg       Date:  1991-11       Impact factor: 6.939

10.  Does neoadjuvant chemoradiation downstage locally advanced pancreatic cancer?

Authors:  Hong Jin Kim; Karen Czischke; Murray F Brennan; Kevin C Conlon
Journal:  J Gastrointest Surg       Date:  2002 Sep-Oct       Impact factor: 3.452

View more
  2 in total

1.  Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head.

Authors:  Quentin Denost; Christophe Laurent; Jean-Philippe Adam; Maylis Capdepont; Veronique Vendrely; Denis Collet; Antonio Sa Cunha
Journal:  HPB (Oxford)       Date:  2013-01-10       Impact factor: 3.647

Review 2.  Liquid Biopsy as a Prognostic and Theranostic Tool for the Management of Pancreatic Ductal Adenocarcinoma.

Authors:  Daniel C Osei-Bordom; Gagandeep Sachdeva; Niki Christou
Journal:  Front Med (Lausanne)       Date:  2022-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.